首页|期刊导航|Global Health Journal|Comparison of the 1st and 24th WHO essential medicines list(1977-2025):identification of "core essential drugs"

Comparison of the 1st and 24th WHO essential medicines list(1977-2025):identification of "core essential drugs"OA

中文摘要

Purpose:The Essential Medicines List(EML),published by the World Health Organization since 1977,provides global guidance for the selection of effective,safe,and essential medicines.Following the publication of the 24th edition in 2025,this study sought to compare nearly five decades of EML development in order to identify and evaluate"core essential drugs"with long-standing use and efficacy.Methods:The 1st(1977)and 24th(2025)edition of the EML were compared in regard to listed drugs.Extracted were explanations for changes and indications to summarize usage fields and generalize patterns.Changes of drug listings were categorized as additions,deletions,or modifications,while drugs retaining were defined as"core essential drugs".Results:The total number of listed drugs increased strongly from 1977 to 2025.Despite this,the proportional distribution of most usage fields remained relatively stable.Anti-infective,antineoplastic,central nervous system,cardiovascular,and immunization-related medicines experienced many changes and represent dynamic categories.In contrast,blood components,nutrition,electrolyte-correcting solutions,and respiratory system demonstrated high preservation rates and can be regarded as comparatively static.143 medicines were identified as core essential drugs retained in both editions.Conclusions:The long-term comparison highlights consistent patterns of both stability and change within the EML.Despite significant therapeutic advancements,a substantial group of core essential drugs has remained central for nearly five decades,reflecting their continued importance in global pharmacotherapy.Identifying which medicines persist and evaluating the reasons for their retention can support evidence-based updates to future EML editions and inform medicine list development.

Lilly Josephine Bindel;Roland Seifert

Institute of Pharmacology,Hannover Medical School,Hannover,GermanyInstitute of Pharmacology,Hannover Medical School,Hannover,Germany

医药卫生

WHOEMLEssential medicinesPublic healthHealth careRational pharmacotherapyMedical innovation

《Global Health Journal》 2026 (2)

P.142-151,10

10.1016/j.glohj.2026.06.010

评论